About this trial
This multinational, investigator-initiated registry aims to investigate clinical outcomes of patients undergoing transcatheter mitral valve replacement (TMVR). The registry primarily focuses on patients treated with TMVR in real-world clinical practice.
Patients evaluated for TMVR but not undergoing the procedure are no longer systematically included. Historical data may include such patients who subsequently underwent alternative treatments, including transcatheter edge-to-edge repair, mitral valve surgery, or medical/conservative therapy.
Eligibility criteria
Qualifiers
clinically significant mitral insufficiency
patient underwent screening for TMVI
echocardiography data at baseline (and after TMVI, E2E and surgery)
follow-up of at least 30 days
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Universitätsklinikum Hamburg-Eppendorf
Lead sponsor
Montreal Heart Institute
Collaborator
University Hospital, Bordeaux
Collaborator